Developing a rapid test for drug responses in tuberculosis
Clinical Studies
This study is working on a fast test to see how tuberculosis germs react to different medicines, and it’s designed for patients to help us learn more about drug resistance so we can improve treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10595536 on NIH RePORTER |
What this research studies
This research focuses on creating a quick molecular diagnostic tool to identify how Mycobacterium tuberculosis (Mtb) responds to various drugs. By involving human subjects, the project aims to enhance the understanding of drug resistance in tuberculosis, which is crucial for effective treatment. The research will implement rigorous protocols to ensure compliance with NIH standards, manage data effectively, and maintain high-quality control throughout the study. Patients will be involved in the collection of specimens and clinical procedures across multiple sites.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with tuberculosis who may be experiencing drug resistance.
Not a fit: Patients with non-tuberculosis related conditions or those who do not have a confirmed diagnosis of tuberculosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnosis of drug-resistant tuberculosis, improving treatment outcomes for patients.
How similar studies have performed: Previous research has shown promise in developing rapid diagnostics for tuberculosis, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Murray, Megan B — Harvard Medical School
- Study coordinator: Murray, Megan B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.